Skip to main content

Table 1 Baseline clinical characteristics of acute stroke patients and healthy controls

From: KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke

Characteristics

Controls (n = 33)

NIHSS < 7 (n = 39)

NIHSS ≥ 7 (n = 35)

Age mean ± SD (years)

64.92 ± 9.16

65.41 ± 10.03

67.54 ± 12.57

Male, n (%)

19 (57.58%)

25 (64.1%)

24 (68.57)

Hypercholesterolemia, n (%)

9 (27.27%)

20 (51.28%)*

19 (54.29%)*

Hypertension, n (%)

15 (45.45%)

26 (66.67%)

26 (74.29%)*

Diabetes, n (%)

4 (12.12%)

11 (28.21%)

12 (34.29%)

Active smoker, n (%)

8 (24.24%)

10 (25.64%)

15 (42.86%)

Alcohol, n (%)

5 (15.15%)

8 (20.51%)

13 (37.14%)

Atrial fibrillation, n (%)

3 (9.09%)

6 (15.38%)

11 (31.43%)*

Coronary disease, n (%)

–

3 (7.69%)

5 (14.26%)

Previous antiplatelet treatment, n (%)

10 (30.3%)

12(30.77%)

13(37.14%)

Previous treatment with statin, n (%)

9 (27.27%)

14 (35.9%)

15 (42.86%)

  1. Minor stroke was defined as NIHSS score < 7, moderate to severe stroke defined as NIHSS score ≥ 7
  2. NIHSS National Institute of Health Stroke Scale, SD standard deviation
  3. *P < 0.05 vs healthy controls